Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Tenet Healthcare Corp (THC): Insiders Aren’t Crazy About It But Hedge Funds Love It

Page 1 of 2

In the 21st century investor’s toolkit, there are dozens of metrics investors can use to watch their holdings. Two of the best are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best investment managers can outpace the market by a very impressive margin (see just how much).

Just as necessary, optimistic insider trading activity is another way to look at the world of equities. Obviously, there are many motivations for an upper level exec to cut shares of his or her company, but only one, very simple reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the valuable potential of this tactic if investors understand where to look (learn more here).

Thus, let’s discuss the latest info about Tenet Healthcare Corp (NYSE:THC).

What does the smart money think about Tenet Healthcare Corp (NYSE:THC)?

In preparation for the third quarter, a total of 42 of the hedge funds we track held long positions in this stock, a change of 14% from the first quarter. With hedge funds’ capital changing hands, there exists a select group of notable hedge fund managers who were boosting their stakes significantly.

Tenet Healthcare Corp (NYSE:THC)According to our 13F database, Larry Robbins’s Glenview Capital had the biggest position in Tenet Healthcare Corp (NYSE:THC), worth close to $453.6 million, comprising 4.2% of its total 13F portfolio. Coming in second is Harris Associates, managed by Natixis Global Asset Management, which held a $355.3 million position; 0.7% of its 13F portfolio is allocated to the company. Some other peers with similar optimism include Robert Pohly’s Samlyn Capital, John Griffin’s Blue Ridge Capital and Daniel Gold’s QVT Financial.

Now, specific money managers were leading the bulls’ herd. Glenview Capital, managed by Larry Robbins, created the most valuable position in Tenet Healthcare Corp (NYSE:THC). Glenview Capital had 453.6 million invested in the company at the end of the quarter. Robert Pohly’s Samlyn Capital also initiated a $98.6 million position during the quarter. The following funds were also among the new THC investors: John Griffin’s Blue Ridge Capital, Daniel Gold’s QVT Financial, and Roberto Mignone’s Bridger Management.

How are insiders trading Tenet Healthcare Corp (NYSE:THC)?

Insider buying is at its handiest when the company in question has experienced transactions within the past 180 days. Over the latest six-month time frame, Tenet Healthcare Corp (NYSE:THC) has seen zero unique insiders buying, and 4 insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Tenet Healthcare Corp (NYSE:THC). These stocks are HCA Holdings Inc (NYSE:HCA), LifePoint Hospitals, Inc. (NASDAQ:LPNT), Health Management Associates Inc (NYSE:HMA), Universal Health Services, Inc. (NYSE:UHS), and Community Health Systems (NYSE:CYH). This group of stocks are the members of the hospitals industry and their market caps are closest to THC’s market cap.

Page 1 of 2
Loading Comments...